Spontaneous Achilles tendon rupture in a patient with systemic lupus erythematosus due to ischemic necrosis after methyl prednisolone pulse therapy

被引:15
作者
Chiou, YM
Lan, JL
Hsieh, TY
Chen, YH
Chen, DY
机构
[1] Natl Yang Ming Univ, Div Rheumatol Allergy & Immunol, Taichung Vet Gen Hosp, Taichung 407, Taiwan
[2] Taipei Med Univ, Sch Med, Taipei, Taiwan
关键词
antiphospholipid antibodies; hyperhomocysteinemia; MTP pulse therapy; protein S deficiency; systemic lupus erythematosus; tendon rupture;
D O I
10.1191/0961203305lu2046cr
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Spontaneous tendon rupture in a patient with systemic lupus erythematosus (SLE) is a rare but potentially disabling complication. Minor trauma, local inflammation and long term corticosteroid therapy are regarded as possible causes. However, ischemic necrosis of the tendon resulting from hypercoagulability and methyl prednisolone (MTP) pulse therapy has not been reported. We present a 20-year old female, newly diagnosed with lupus, who has high titer antiphospholipid antibodies, hyperhomocysteinemia and protein S deficiency. Her severe clinical symptoms of lupus were improved after MTP pulse therapy. Several days later, cold sensation over the right lower leg developed. On day 15 after pulse therapy, acute onset of right heel pain occurred when she was ascending stairs. Rupture of the right Achilles tendon was demonstrated by sonography and MRI. A Doppler sonography revealed narrowing and abrupt cessation of blood flow in the right popliteal artery. Heparin treatment was started. The angiography performed two days after heparinization revealed narrow caliber and decreased flow of the right tibial artery below the right ankle. Surgical repair of the tendon was successful and the pathology of the resected tendon revealed focal necrosis, degeneration and capillary proliferation. MTP pulse therapy in a lupus patient with hypercoaguable state with hyperhomocysteinemia, protein S deficiency and high titer antiphospholipid antibodies may cause spontaneous tendon rupture.
引用
收藏
页码:321 / 325
页数:5
相关论文
共 13 条
[1]  
Ames PRJ, 1996, THROMB HAEMOSTASIS, V76, P190
[2]   THROMBOEMBOLIC COMPLICATIONS ASSOCIATED WITH ACTH AND CORTISONE THERAPY [J].
COSGRIFF, SW .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1951, 147 (10) :924-926
[3]   CORTICOSTEROID-ASSOCIATED BLUE TOE SYNDROME - ROLE OF ANTIPHOSPHOLIPID ANTIBODIES [J].
DAVIES, GE ;
TRIPLETT, DA .
ANNALS OF INTERNAL MEDICINE, 1990, 113 (11) :893-895
[4]   TENDON-RUPTURE IN SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
FURIE, RA ;
CHARTASH, EK .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 1988, 18 (02) :127-133
[5]   Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [J].
Hochberg, MC .
ARTHRITIS AND RHEUMATISM, 1997, 40 (09) :1725-1725
[6]  
LONG AA, 1991, THROMB HAEMOSTASIS, V66, P520
[7]   CORTICOSTEROIDS - DO THEY DAMAGE THE CARDIOVASCULAR-SYSTEM [J].
MAXWELL, SRJ ;
MOOTS, RJ ;
KENDALL, MJ .
POSTGRADUATE MEDICAL JOURNAL, 1994, 70 (830) :863-870
[8]   EFFECTS OF CORTICOSTEROIDS ON COAGULATION OF BLOOD [J].
OZSOYLU, S ;
STRAUSS, HS ;
DIAMOND, LK .
NATURE, 1962, 195 (4847) :1214-&
[9]  
OZTURK G, 1994, EUR J HAEMATOL, V53, P119
[10]  
PRITCHARD CH, 1989, J RHEUMATOL, V16, P786